Coca-Cola Europacific Partners Plc (CCEP) concluded trading on Wednesday at a closing price of $85.09, with 6.58 million shares of worth about $559.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.78% during that period and on April 09, 2025 the price saw a gain of about 3.97%. Currently the company’s common shares owned by public are about 474.92M shares, out of which, 215.27M shares are available for trading.
Stock saw a price change of -2.65% in past 5 days and over the past one month there was a price change of 2.06%. Year-to-date (YTD), CCEP shares are showing a performance of 10.78% which increased to 23.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $65.94 but also hit the highest price of $91.29 during that period. The average intraday trading volume for Coca-Cola Europacific Partners Plc shares is 2.59 million. The stock is currently trading -0.09% below its 20-day simple moving average (SMA20), while that difference is up 1.35% for SMA50 and it goes to 8.29% higher than SMA200.
Coca-Cola Europacific Partners Plc (NASDAQ: CCEP) currently have 474.92M outstanding shares and institutions hold larger chunk of about 33.41% of that.
The stock has a current market capitalization of $39.21B and its 3Y-monthly beta is at 0.72. PE ratio of stock for trailing 12 months is 25.58, while it has posted earnings per share of $3.33 in the same period. Its PEG reads 2.90 and has Quick Ratio of 0.62 while making debt-to-equity ratio of 1.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCEP, volatility over the week remained 4.85% while standing at 2.52% over the month.
Stock’s fiscal year EPS is expected to rise by 7.63% while it is estimated to increase by 8.49% in next year. EPS is likely to grow at an annualized rate of 8.83% for next 5-years, compared to annual growth of 4.96% made by the stock over the past 5-years.
On December 03, 2024, Bernstein Initiated their recommendations, while on November 27, 2024, JP Morgan Downgrade their ratings for the stock with a price target of $82. Stock get a Neutral rating from Exane BNP Paribas on September 10, 2024.
